2026/02/03 by Ronald C. Kessler · 1 voice
Psychology · #Mental Health Research Topics #Mental Health Treatment and Access #Suicide and Self-Harm Studies
paper · doi:10.61373/gp026k.0021
openalex publication_date 2026/02/03 · openalex created_date 2026/02/04 · openalex updated_date 2026/05/21
Widely recognized as the world's most published and influential psychiatric epidemiologist, Dr. Ronald C. Kessler is the McNeil Family Professor of Health Care Policy at Harvard Medical School, with secondary appointments as Professor of Epidemiology at the Harvard T.H. Chan School of Public Health, Program Director at the University of Michigan Institute for Social Research, and at the Massachusetts General Hospital Center for Precision Psychiatry. Known for leading major national and global epidemiological surveys on the population prevalence and correlates of mental disorders, he has transformed how the field understands the burden, distribution, and treatment of common mental illnesses and suicide-related behaviors. Dr. Kessler was the Principal Investigator of the US National Comorbidity Survey, the first nationally representative survey of mental disorders in the United States, and a series of follow-up and replication studies that have mapped changes in mental health and service use over time. For two decades, he served as Director of the World Health Organization World Mental Health Survey Initiative, a program of community surveys in over 30 countries that has provided the empirical foundation for national mental health policies and resource allocation decisions worldwide. Building on this foundation, his more recent work extends into high-risk populations through large-scale studies such as the Army STARRS and STARRS-LS initiatives. Dr. Kessler is the most cited author in psychiatry and psychology worldwide, with more than 1,300 scientific publications, cited over 330,000 times; h-index: 271 (Scopus), 354 (Google Scholar, January 2026). He has been a pioneer in the use of sophisticated methods for conducting and analyzing general population psychiatric epidemiologic surveys. In recent years, he has extended this work to implement clinical epidemiologic surveys, use these surveys to develop clinical decision support tools, and conduct pragmatic precision treatment trials to assess the value of these clinical decision support tools to prevent and treat depression, anxiety, and suicide. Dr. Kessler's achievements have been recognized with election to the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences. This Genomic Press Interview offers an in-depth look at the trajectory, methods, and vision of a scientist whose work has reshaped modern psychiatric and mental health epidemiology and the global conversation about mental health.